Cogent Biosciences (COGT) announced preclinical data from four pipeline programs during poster sessions at the American Association for Cancer ...

All posters will be available on the ‘Posters and Publications’ page of Cogent’s website. New Leadership Appointments Cogent also announced today that Ray Frost has joined Cogent as Senior Vice ...

HER2 (ERBB2) gene change. HER2 protein promotes the growth of cancer cells. HER2 inhibitors such as fam-trastuzumab deruxtecan (Enhertu) and ado-trastuzumab emtansine (Kadcyla) can help slow down ...

USC has a unique gene expression profile ... molecular markers for targeted therapy in USC are being studied. erbB2 is overexpressed in 20–50% of USC patients. erbB2 is more frequently ...